Faron Pharmaceuticals Oy (OHEL:FARON)
€ 1.91 -0.01 (-0.52%) Market Cap: 191.86 Mil Enterprise Value: 174.61 Mil PE Ratio: 0 PB Ratio: 139.64 GF Score: 36/100

Faron Pharmaceuticals Oy at Canaccord Genuity Growth Conference Transcript

Aug 10, 2023 / 04:30PM GMT
Release Date Price: €2.86 (-1.98%)
John Newman
Canaccord Genuity Group Inc. - Analyst

Good afternoon, everyone, and thank you for joining us at the 43rd Annual Canaccord Genuity Growth Conference. I'm John Newman, one of the biotech analysts here at Canaccord based in New York.

We're very excited to have Faron with us today. And joining us are the CEO, Markku Jalkanen; and the CMO, Marie-Louise Fjällskog. So welcome to you both.

Marie;Louise FjÃ;llskog
Faron Pharmaceuticals Oy - Chief Medical Officer

¤ -

Thank you.

Questions & Answers

John Newman
Canaccord Genuity Group Inc. - Analyst

I'm going to take a seat over here now. So thanks for joining us. I'm wondering if we could start by talking about your lead assets, excuse me, bexmarilimab. I believe this targets something called Clever-1. Could you first talk to us about the importance of this target, biologically?

Markku Jalkanen
Faron Pharmaceuticals Oy - CEO & Executive Director

Absolutely.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot